What to Learn from US FDA Warning Letters and Their Impact on Pharmacovigilance Operations

This webinar will evaluate warning letters from the perspective of small and large pharmaceutical companies. The expert PV panel will present best practices and recommendations that can be employed to improve a PV organization's structure, develop appropriate SOPs and processes, track important PV functions, and ensure inspection readiness.